Autocrine epidermal growth factor signaling stimulates directionally persistent mammary epithelial cell migration.
Cell responses to soluble regulatory factors may be strongly influenced by the mode of presentation of the factor, as in matrix-bound versus diffusible modes. The possibly diverse effect of presenting a growth factor in autocrine as opposed to exogenous (or paracrine) mode is an especially important issue in cell biology. We demonstrate here that migration behavior of human mammary epithelial cells in response to stimulation by epidermal growth factor (EGF) is qualitatively different for EGF presented in exogenous (paracrine), autocrine, and intracrine modes. When EGF is added as an exogenous factor to the medium of cells that express EGF receptor (EGFR) but not EGF, cell migration speed increases while directional persistence decreases. When these EGFR-expressing cells are made to also express via retroviral transfection EGF in protease-cleaveable transmembrane form on the plasma membrane, migration speed similarly increases, but directional persistence increases as well. Addition of exogenous EGF to these cells abrogates their enhanced directional persistence, reducing their directionality to a level similar to wild-type cells. If the EGFR-expressing cells are instead transduced with a gene encoding EGF in a soluble form, migration speed and directional persistence were unaffected. Thus, autocrine presentation of EGF at the plasma membrane in a protease-cleavable form provides these cells with an enhanced ability to migrate persistently in a given direction, consistent with their increased capability for organizing into gland-like structures. In contrast, an exogenous/paracrine mode of EGF presentation generates a "scattering" response by the cells. These findings emphasize the functional importance of spatial restriction of EGFR signaling, and suggest critical implications for growth factor-based therapeutic treatments.
Maheshwari
G
G
Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Wiley
H S
HS
Lauffenburger
D A
DA
D019898:Autocrine Communication / Q000502:physiology*; D001940:Breast / Q000166:cytology*; D002460:Cell Line; D002465:Cell Movement / Q000502:physiology*; D016895:Culture Media, Serum-Free; D004815:Epidermal Growth Factor / Q000494:pharmacology*; D004847:Epithelial Cells / Q000187:drug effects / Q000502:physiology*; D066246:ErbB Receptors / Q000502:physiology*; D005260:Female; D005456:Fluorescent Dyes; D006801:Humans; D008856:Microscopy, Fluorescence; D015398:Signal Transduction / Q000187:drug effects*
D016895:Culture Media, Serum-Free; D005456:Fluorescent Dyes; D004815:Epidermal Growth Factor; D066246:ErbB Receptors